Cargando…
RNAseq Analysis of Novel 1,3,4-Oxadiazole Chalcogen Analogues Reveals Anti-Tubulin Properties on Cancer Cell Lines
1,3,4-Oxadiazole derivatives are among the most studied anticancer drugs. Previous studies have analyzed the action of different 1,3,4-oxadiazole derivatives and their effects on cancer cells. This study investigated the characterization of two new compounds named 6 and 14 on HeLa and PC-3 cancer ce...
Autores principales: | Zoroddu, Stefano, Sanna, Luca, Bordoni, Valentina, Lyu, Weidong, Murineddu, Gabriele, Pinna, Gerard A., Forcales, Sonia Vanina, Sala, Arturo, Kelvin, David J., Bagella, Luigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10379353/ https://www.ncbi.nlm.nih.gov/pubmed/37511023 http://dx.doi.org/10.3390/ijms241411263 |
Ejemplares similares
-
Silver Nanoparticles Derived by Artemisia arborescens Reveal Anticancer and Apoptosis-Inducing Effects
por: Bordoni, Valentina, et al.
Publicado: (2021) -
Synthesis, molecular docking study and anticancer activity of novel 1,3,4-oxadiazole derivatives as potential tubulin inhibitors
por: Yousef, Tarek A., et al.
Publicado: (2023) -
Bromodomain Inhibitor JQ1 Provides Novel Insights and Perspectives in Rhabdomyosarcoma Treatment
por: Marchesi, Irene, et al.
Publicado: (2022) -
Synthesis and Anticancer Activity of N-Aryl-5-substituted-1,3,4-oxadiazol-2-amine Analogues
por: Ahsan, Mohamed Jawed, et al.
Publicado: (2014) -
Synthesis, Characterization, and In Vitro Anticancer Evaluation of Novel 2,5-Disubstituted 1,3,4-Oxadiazole Analogue
por: Salahuddin,, et al.
Publicado: (2014)